11 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
8 Aug 18
Coherus BioSciences Reports Corporate Highlights and Second Quarter 2018 Financial Results
4:10pm
and Green, where he advises life science companies, health care systems and provider organizations.
In May 2018, Coherus completed an underwritten
8-K
EX-99.1
dwkghifmlaihwh s7
14 May 18
Departure of Directors or Certain Officers
5:22pm
8-K
izzj3 lou863
14 May 18
Departure of Directors or Certain Officers
5:22pm
DRS
EX-10.8
gfwl nbv2hg79ly
4 Aug 14
Draft registration statement
12:00am
DRS
EX-10.8
91is6l57z
4 Aug 14
Draft registration statement
12:00am
DRS
EX-4.3
p72 fxxl961h0sqm77f
4 Aug 14
Draft registration statement
12:00am
- Prev
- 1
- Next